Page 2 - Ryan Weispfenning News Today

DUBLIN, Feb. 29, 2024 /PRNewswire/ -- Medtronic , the global leader in healthcare technology, today announced it filed a complaint with the U.S. International Trade Commission , along with a...

Medtronic plc (NYSE:MDT) Q3 2024 Earnings Call Transcript February 20, 2024 Medtronic plc beats earnings expectations. Reported EPS is $1.3, expectations were $1.26. Medtronic plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Ryan Weispfenning: [Video Presentation] Good morning and welcome […]

Delivers on commitments with strong growth in Core Spine, Cardiac Surgery, Structural Heart, Cardiac Pacing, and across many international markets; Diabetes increases double digits as U.S. business...

MDT earnings call for the period ending December 31, 2023.

MDT earnings call for the period ending December 31, 2023.

/CNW/ -- Medtronic plc (NYSE:MDT) today announced financial results for its third quarter (Q3) of fiscal year 2024 (FY24), which ended January 26, 2024. Key...

With CE Mark approval, the benefits of the MiniMed™ 780G system are now available with a new sensor that takes less than 10 seconds to insert1 DUBLIN, Jan. 8, 2024 /PRNewswire/ -- Medtronic plc ,...

Rechargeable neurostimulator joins the Medtronic Percept™ family – the first and only deep brain stimulation system with sensing, directionality, and advanced programming. DUBLIN, Jan. 8, 2024...

/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval of its...

New pacemakers offer 40% more battery life,1 extend Medtronic legacy of pacing leadership DUBLIN, Jan. 5, 2024 /PRNewswire/ -- Medtronic plc , a global leader in healthcare technology, today...